Mangel R - Search Results

1

Recovery of graft function early posttransplant determines long-term graft survival in deceased donor renal transplants.

Hassanain M, Tchervenkov JI, Cantarovich M, Metrakos P, Paraskevas S, Keith D, Baran D, Fernandez M, Mangel R, Chaudhury P. Hassanain M, et al. Among authors: mangel r. Transplant Proc. 2009 Jan-Feb;41(1):124-6. doi: 10.1016/j.transproceed.2008.10.046. Transplant Proc. 2009. PMID: 19249494

2

Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors.

Hassanain M, Tchervenkov J, Cantarovich M, Metrakos P, Paraskevas S, Keith D, Baran D, Fernandez M, Mangel R, Chaudhury P. Hassanain M, et al. Among authors: mangel r. Transplant Proc. 2009 Jan-Feb;41(1):133-4. doi: 10.1016/j.transproceed.2008.10.044. Transplant Proc. 2009. PMID: 19249497

3

Reduced dose Thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes.

Tan M, Cantarovich M, Mangel R, Paraskevas S, Fortier M, Metrakos P. Tan M, et al. Among authors: mangel r. Clin Transplant. 2002 Dec;16(6):414-8. doi: 10.1034/j.1399-0012.2002.02031.x. Clin Transplant. 2002. PMID: 12437620

4

Quebec Metro-Transplantation Multicenter Study on delayed graft function in kidney transplantation.

Corman J, Moukarzel M, Guttmann R, Dandavino R, St-Louis G, Clermont MJ, Mangel R, Lachance JG. Corman J, et al. Among authors: mangel r. Transplant Proc. 1988 Feb;20(1 Suppl 1):428-31. Transplant Proc. 1988. PMID: 3279632 No abstract available.

5

[Development of organ transplantation in Quebec from 1985 to January 1990].

Corman J, Clermont MJ, Dandavino R, Daloze P, Lachance JG, Mangel R, Corcos J, Chartrand C, Poirier N, Marleau D, et al. Corman J, et al. Among authors: mangel r. Ann Chir. 1991;45(9):791-5. Ann Chir. 1991. PMID: 1781622 French.

6

Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: implications for atherogenic risk.

Lowry RP, Soltys G, Peters L, Mangel R, Sniderman AD. Lowry RP, et al. Among authors: mangel r. Transplant Proc. 1987 Aug;19(4):3426-30. Transplant Proc. 1987. PMID: 3303510 No abstract available.

7

Metabolic acidosis during urinary retention in a patient with an enterovesical fistula.

Gagnon RF, Mangel R, Kaye M. Gagnon RF, et al. Among authors: mangel r. Clin Nephrol. 2000 Jul;54(1):73-7. Clin Nephrol. 2000. PMID: 10939761

8

Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.

Lowry RP, Soltys G, Mangel R, Kwiterovitch P, Sniderman AD. Lowry RP, et al. Among authors: mangel r. Transplant Proc. 1987 Feb;19(1 Pt 3):2229-32. Transplant Proc. 1987. PMID: 3547921 No abstract available.

9

Regulation of the plasma ionized calcium and its therapeutic control in patients treated by regular hemodialysis.

Kaye M, Cohen GF, Chatterjee G, Mangel R. Kaye M, et al. Among authors: mangel r. Trans Am Soc Artif Intern Organs. 1969;15:341-6. Trans Am Soc Artif Intern Organs. 1969. PMID: 5791407 No abstract available.

10

Three years' experience with bypass cannulae for chronic hemodialysis.

Keon WJ, Mangel R, Kaye M. Keon WJ, et al. Among authors: mangel r. Can Med Assoc J. 1967 Mar 4;96(9):524-7. Can Med Assoc J. 1967. PMID: 6019351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters